A New and Emerging Technology Briefing from the National Horizon Scanning Centre on the use of eltrombopag (SB 497115) in refractory chronic immune (or idiopathic) thrombocytopenic purpura.

Eltrombopag (SB 497115, Revolade, Promacta) is an oral non-peptide thrombopoietin receptor agonist that increases platelet counts by stimulating the differentiation and proliferation of bone marrow megakaryocytes.